UBS Group
HSACU

UBS Group’s Health Sciences Acquisitions Corporation Units HSACU Stock Holding History

UBS Group’s Portfolio HSACU Stock Details HSACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,308
Closed -$164K – 8696
2019
Q3 		$164K Sell
15,308
-9,692
-39% -$104K ﹤0.01% 5407
2019
Q2 		$265K Buy
+25,000
New +$260K ﹤0.01% 4733

UBS Group's HSACU Position: Q4 2019 in Review

UBS Group sold out of Health Sciences Acquisitions Corporation Units (HSACU) in Q4 2019, closing a stake of 15,308 shares — an estimated $164K sold.

UBS Group first reported a position in HSACU in Q2 2019 and held it in 2 quarters. The position peaked at $265K in Q2 2019. 0 funds tracked by Wall St. Rank hold HSACU as of Q4 2019.

  • UBS Group reported no remaining Health Sciences Acquisitions Corporation Units position as of Q4 2019 after selling out during the quarter.
  • UBS Group sold 15,308 Health Sciences Acquisitions Corporation Units shares in Q4 2019, an estimated $164K.
  • UBS Group first reported a position in Health Sciences Acquisitions Corporation Units in Q2 2019 and held it in 2 quarters.
  • UBS Group's Health Sciences Acquisitions Corporation Units position peaked at $265K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Health Sciences Acquisitions Corporation Units as of Q4 2019.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.